Wnt Signaling Pathway and AD

Similar documents
Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases

How Nicotinic Signaling Shapes Neural Networks

Selective filtering defect at the axon initial segment in Alzheimer s disease mouse models. Yu Wu

9.01 Introduction to Neuroscience Fall 2007

SUPPLEMENTARY INFORMATION

ALZHEIMER S DISEASE FACTOIDS & STATISTICS

Targeting the p75 Receptor to Inhibit Degenerative Signaling and Tau Phosphorylation/Misfolding/ Missorting: Preclinical through Phase 1

BIPN 140 Problem Set 6

BIPN 140 Problem Set 6

Lack of evidence of the interaction of the Aβ peptide with the Wnt signaling cascade in Drosophila models of Alzheimer s disease

Part 11: Mechanisms of Learning

Cellular Neurobiology / BIPN 140

Neural Development. Open Access. Abstract

TGF-ß1 pathway as a new pharmacological target for neuroprotection in AD. Filippo Caraci

CASE 49. What type of memory is available for conscious retrieval? Which part of the brain stores semantic (factual) memories?

Functional Development of Neuronal Networks in Culture -An in vitro Assay System of Developing Brain for Endocrine Disruptors

Supporting Information

Signaling pathway cross talk in Alzheimer s disease

Synaptic plasticityhippocampus. Neur 8790 Topics in Neuroscience: Neuroplasticity. Outline. Synaptic plasticity hypothesis

Synaptic Communication. Steven McLoon Department of Neuroscience University of Minnesota

Psych 181: Dr. Anagnostaras

Protein Kinase C Modulates Wnt Signaling In Colon Tumoral Cell Lines

Synaptic Integration

1) Drop off in the Bi 150 box outside Baxter 331 or to the head TA (jcolas).

Neuronal Differentiation: CNS Synapse Formation

TAU PATHOLOGY REDUCTION WITH SM07883, A NOVEL, POTENT, AND SELECTIVE ORAL DYRK1A INHIBITOR - A POTENTIAL THERAPEUTIC FOR ALZHEIMER S DISEASE

Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD

Charlie Taylor, PhD CpTaylor Consulting Chelsea, MI, USA

Supplementary Figure 1. mir124 does not change neuron morphology and synaptic

BIPN140 Lecture 13: Synapse Formation (Synaptogenesis)

Activity Dependent Changes At the Developing Neuromuscular Junction

Mecanismo de acción de Souvenaid: nuevos datos preclínicos

Appendix A14.15 The Wnt Signaling Pathway: An Overview

Synapse Formation. Steven McLoon Department of Neuroscience University of Minnesota

Ionotropic glutamate receptors (iglurs)

Preconditioning the Brain for Stroke Prevention

University of Bristol - Explore Bristol Research. Peer reviewed version. Link to published version (if available): /jnc.

9.01 Introduction to Neuroscience Fall 2007

Bioscience in the 21st century

Synaptic plasticity. Activity-dependent changes in synaptic strength. Changes in innervation patterns. New synapses or deterioration of synapses.

Synaptic Plasticity and Memory

TAU PATHOLOGY REDUCTION WITH SM07883, A NOVEL, POTENT, AND SELECTIVE ORAL DYRK1A INHIBITOR - A POTENTIAL THERAPEUTIC FOR ALZHEIMER S DISEASE

Perspective. Malignant synaptic growth and Alzheimer s disease. Future Neurology. For reprint orders, please contact:

Anatomy of a Neuron. Copyright 2000 by BSCS and Videodiscovery, Inc. Permission granted for classroom use. Master 2.1

Defeating Alzheimer disease and dementia when will we get the cure?

A new approach to Common Sporadic Alzheimer s, Post-Traumatic Alzheimer s, and CTE:

Structure of a Neuron:

The Potential Effect of Caffeine and Nicotine Co-administration on the Induction of Alzheimer s disease

BIOLOGICAL PROCESSES

SUPPLEMENTARY INFORMATION

Ube3a is required for experience-dependent maturation of the neocortex

How Synapses Integrate Information and Change

Alzheimer s disease (AD) is a neurodegenerative disease whose most common symptom is a progressive loss of cognitive functions and intellectual

Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory

Novel drug developed to treat type 2 diabetes are neuroprotective Alzheimer s disease

Communication Between

How Synapses Integrate Information and Change

Cellular Neurobiology BIPN140

The effect of diets on neurodegenerative diseases

TITLE: Altered Astrocyte-Neuron Interactions and Epileptogenesis in Tuberous Sclerosis Complex Disorder

BIPN140 Lecture 12: Synaptic Plasticity (II)

Neuronal Plasticity, Learning and Memory. David Keays Institute of Molecular Pathology

Synaptic changes in dementia: links to cognition and behaviour

Nigel Hooper. University of Manchester UK

Lecture 7: Roles for MAGUKS in Activity-dependent Synaptogenesis MCP

Research Development: Bedside to Bench and Back

Supplementary Figure 1. Basic properties of compound EPSPs at

Synaptic Plasticity and NO-cGMP-PKG Signaling Regulate Pre- and Postsynaptic Alterations at Rat Lateral Amygdala Synapses Following Fear Conditioning

Introduction to Neurobiology

Sharon Shacham, Ph.D. ICAD, July 29th, 2008 NASDAQ: EPIX

D espite much evidence for a central role of amyloid-beta (Ab) in the pathogenesis of Alzheimer s disease,

Human Brain and Senses

Wnt Signaling Mediates Experience-Related Regulation of Synapse Numbers and Mossy Fiber Connectivities in the Adult Hippocampus

Introduction. up regulated include genes associated with stress response, DNA repair and

WNT5A Signaling Contributes to A beta-induced Neuroinflammation and Neurotoxicity

Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy

Basal Ganglia Anatomy, Physiology, and Function. NS201c

Memory Systems II How Stored: Engram and LTP. Reading: BCP Chapter 25

Address: th Ave W Bradenton, FL Toll Free Tel: (877) Toll Free Fax: (866)

Diabetes Mellitus and Dementia. Andrea Shelton & Adena Zadourian

Developmental regulation of Medium Spiny Neuron dendritic arborization. Lorene M. Lanier Department of Neuroscience

Alzheimer's Disease A mind in darkness awaiting the drink of a gentle color.

- Neurotransmitters Of The Brain -

Basic elements: Neurons and Glia. Mary ET Boyle, Ph. D. Department of Cognitive Science, UCSD

NEURONS COMMUNICATE WITH OTHER CELLS AT SYNAPSES 34.3

Nataliya Golovyashkina 1, Lorène Penazzi 1, Carlo Ballatore 2,3, Amos B. Smith III 2, Lidia Bakota 1 and Roland Brandt 1*

Postsynaptic scaffold proteins in health and disease Dr. Jonathan Hanley

Communication Between Neurons *

Synapses. Objectives. Synaptic Relationships Between Neurons. Structure of a Chemical Synapse. Structure of a Chemical Synapse

Outline. Neuron Structure. Week 4 - Nervous System. The Nervous System: Neurons and Synapses

MOLECULAR AND CELLULAR NEUROSCIENCE

IBRO CIHR & UNESCO ADVANCED BEHVIOURAL NEUROSCEINCE SCHOOL KENYA 2008

The Calpain / Calpastatin System in TBI and Chronic Neurodegeneration

Synaptic Transmission: Ionic and Metabotropic

BIPN140 Lecture 8: Synaptic Transmission II

Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment

KHALED ALHOSAINI OFFICE; 2B91 TEL; ; Website;

Body control systems. Let s start at the top: the human brain. The Cerebrum. The human brain. What parts of your brain are you using right now?

Transcription:

Center for Cell Regulation and Pathology Joaquín V. Luco (CRCP), Millennium Institute (MIFAB) Center for Aging and Regeneration (CARE). Wnt Signaling Pathway and AD Nibaldo C. Inestrosa European Union Funding for AD The ADIT Project, SIENABIOTECH Praha, 10 th March, 2009

Why Wnt Signaling is important to study? because it might has the key to understand Alzheimer s Neurodegeneration Tau kinase I is GSK-3b (Takashima et al 1993). Presenilin interacts with d-catenin (Kosik, 1997). b-catenin decreases almost 60% in the brain of AD (m PS1) patients (Yankner,1999) Li protects neurons from Ab neurotoxicity (Avila, 1999). DKK 1 increased in neurons treated with Ab (Caricasole, 2003) Inhibition of GSK-3b by Li, correlates with reduced tauopathy and neurodegeneration in vivo (Duff, 2005). Genetic Polymorphisms in GSK-3b & LRP5/6 genes (2007-2008) Normal brain Tau Phosphorylation AD brain P P Intracellular Amyloid Formation

In 1999, we postulated that b-amyloid neurotoxicity results in the loss of function of Wnt Signaling, this suggested for the first time, that a single pathway can integrates the hallmark lesions of AD: Amyloid Deposits & Neurofibrillary Tangles GSK-3 activation Vicious cycle IntracellularAmyloid formation (PS1 dependent) b-catenin degradation no signaling loss of cell junctions Tau phosphorylation Apoptosis Extracellular Amyloid Loss of synapses, Neuronal cell death AD De Ferrari & Inestrosa; Brain Res. Rev. 33: 1-12, 2000)

Wnt Signaling Pathway WNT DKK1 Ab Frizzled R LRP 6 WNT Frizzled R LRP 6 Axin dishevelled dishevelled APC Axin GSK-3ß ß-catenin P P degradation APC GSK-3ß ß-catenin ß-catenin ß-catenin ß-catenin ß-catenin TCF/ Lef TCF/ Lef

Activation of the Wnt pathway prevents Ab-Neurotoxicity Ab + Wnt HMW Neurofilament Synapsin-1 Exp. Cell Res. 297: 186-196 (2004) Prog. Neurobiol. 86: 281-296 (2008)

Activation of Several Signaling Pathways Results in the Cross-Talk with the Wnt Pathway and Leads to Neuroprotection Against Ab-Toxicity Ab Wnt Fzd Nicotinic Agonist 7 AChR Muscarinic Agonist Plasma Membrane CK1 Dvl Axin Ca 2+ PKC m1achr IBU-PO anti-inflammatory plus anti-ache PS GSK-3b APC b-cat PPAR- Antidiabetic drug Endoplasmic Reticulum APP b-cat Antioxidant Wnt Wnt Target Target Genes Nucleus Farias et al., Neurobiol. Dis. 17: 337-348 (2004) Inestrosa et al., Exp Cell Res. 304:91-104 (2005) Farías et al., Neurobiol. Dis. 18: 176-1183 (2005) Quintanilla et al J. Biol. Chem. 280: 11615-11625 (2005)

Lithium and Rosiglitazone (RGZ) improve Flexibility Memory (Episodic-like memory) in double APP+PS-1 transgenic mice Double Transgenic mouse APPswe + PSEN1D E9 day 1 Tg Control day2 Tg Lithium ThS day3 Tg RGZ WT day 4 Aβ Starting point TREATMENT OF ANIMALS: 6 month-old. LiCl (3 meq/kg day IP). RGZ (3 mg/kg day Gavage). Treatment for 4 months starting at month 6, until month 10.

Lithium and RGZ did not change de number of Amyloid Plaques as studied by Thioflavine-S in the APP/PS-1 mice, but decrease the ratio of ThS Plaques / Ab Aggregates Tg Control Tg Li Tg RGZ Hippocampus Cortex ThS Area (pix 2 ) ThS Area (pix 2 ) 800 700 600 500 400 300 200 100 0 Tg Control Tg Lithium Tg RGZ Hippocampus Mol. Psychiat. (2009) Submitted 700 600 500 400 300 200 100 0 Tg Control Tg Lithium Tg RGZ Cortex Ratio ThS Plaque / Ab Agregates 4 3 2 1 0 Control APP + PS-1 mice Li RGZ

Wnt components Lithium and RGZ increase Wnt components and decrease Ab oligomers in APP-PS1 mice Ab Oligomers Mol. Psychiat. (2009) Submitted

Role of Wnt Signaling in Pre-Synaptic Function Wnt-7a, but not Wnt - 5a, Induces clustering of Synaptophysin Pre-Synaptic Differentiation Wnt Control sv Wnt 7a Pre-Synaptic Aggregation of Synaptic Vesicles Wnt 5a p-synaptophysin (puncta /10mm axon length) 6 4 2 J. Biol. Chem. 283: 5918-5927 (2008) 0 C Wnt 5a Wnt 7a

Wnt-7a increases the frequency of the mepsc A control B Wnt-7a 50pA 100ms C D Amplitude Frequency 2.0 1.5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 Control Wnt-7a E Acumulative Probability 1.0 0.5 0.0 control Wnt-7a 0 30 60 90 mepsc frequency (s ) -1 J. Biol. Chem. 283: 5918-5927 (2008)

7-nAChRs and APC co-localized in pre-synaptic regions of hippocampal neurons exposed to Wnt-7a Synaptotag APC A7 AChR Merge 3.0 pcdna a b c d Clusters size (Relative units) 2.0 1.0 Wnt-7a e f g h 0.0 pcdna Wnt-7a pcdna Wnt-7a pcdna Wnt-7a Synaptotag APC 7 nachr J. Neurosci. 27 (2007) 5313-5325.

Wnt-7a APC 7 nachr Pre-synaptic terminal Ca ++ glutamate GABA Modulation of Synaptic Activity

stimulates Post-synaptic Differentiation sv PSD- 95 Control Wnt - 5a induces clustering of PSD-95 (using GFP-PSD-95) IUBMB Life 59: 316-321 (2007)

increases both PSD-95 clusters in dendritic spines and field EPSC (at the Amplitude level) suggesting a post-synaptic effect. a d 160 PSD-95/ Phalloidin b c Control /sfrp PSD-95 clusters (number/100 mm neurite) 120 80 40 0 Control / sfrp + anti- antibody J. Biol. Chem. (2009) In Press)

Increases Amplitude of the NMDA currents in two phases. sfrp, a Wnt antagonist, blocks the effect 2.0 pcdna 1.0 Normalized Amplitude 0.0-10 -5 0 5 10 15 20 25 30 35 40 45 50 55 60 2.0 1.0 + sfrp Time (min) Wnt sfrp frizzled 0.0-10 -5 0 5 10 15 20 25 30 35 40 45 50 55 60 Time (min) Conditioned medium 1/5 2mM NBQX Membrane potential +40mV

Non-canonical Wnt pathways

BAPTA prevents the effect of on NMDA currents, indicating that Ca +2 entry is required for the Wnt effect Normalized Amplitude 2.0 1.0 0.0 10mM BAPTA -10-5 0 5 10 15 20 25 30 35 40 45 50 55 60 Time (min) PKC inhibition prevents the early and JNK inhibition prevents the late effect of, indicating that the Wnt / Ca +2 and the Wnt / JNK pathways are implicated A 2.0 A 2.0 1.0 1.0 200nM Go6976 (PKC inhib) 0.0-10 -5 0 5 10 15 20 25 30 35 40 45 50 55 60 Time (min) 1.7mM TAT-TI- JIP (JNK inhib) 0.0-15 -10-5 0 5 10 15 20 25 30 35 40 45 50 55 60 Time (min)

Pre-Synaptic Modulation Canonical Wnt Signaling NMDA-R Ab Post-Synaptic Modulation Non-Canonical Wnt Signaling PKC Fzd PSD-95 JNK New Synapses Cytoskeleton

Ab oligomers decreased PSD-95 levels, however prevents such changes PSD-95 PSD-95 / Synapsin-1 / Phalloidin b-tubulin PSD-95 (% of control) 100 80 60 40 20 0 Ab (mm) 0.05 0.5 0.05 0.5 + + + PSD-95 Synapsin-1

Normalized Amplitude Facilitation index R2-R1/R1 Y Axis Title induces the clustering of NMDA receptors in the postsynaptic region. Ab oligomers decrease both NMDA R and field EPSP amplitude in hippocampal slices. prevents these changes. 0.00E+000 control90-2.00e-009-4.00e-009 200pA 25ms NR2B / Phalloidin NMDA R (puncta /10 mm neurite) 5 4 3 2 1 0 - + - + Ab oligom - + + 3 2 1 Control Ab olig Ab olig + -6.00E-009 0-200 0 200 400 600 800 1000 1200 1400 1600 Normalized Amplitude 1.0 control 0 Wnt-7a X Axis Title Control Ab Ab + 1.0 0.5 0.0 co

Ab oligomers decrease: PSD-95, NMDA Receptors, Dendritic Spines, EPSPs, CONCLUSION But the activation of the Non-Canonical Wnt Signaling prevents such changes, including and a formylated hexapeptide NMDA R PSD-95 Fz R Ab PSD-95

Center for Cell Regulation and Pathology Joaquín V. Luco (CRCP), MIFAB & Center of Aging and Regeneration P. Catholic University of Chile Iván Alfaro Waldo Cerpa Margarita Dinamarca Ginny Farias Juan Godoy Catalina Grabowski Enrique Toledo Christian Bonansco & Marcos Fuenzalida Program of Neurosciences Universidad de Valparaiso (Chile) Andrés Barría Department of Physiology University of Washington, Seattle (USA) Jesús Avila Centro de Biología Molecular Severo Ochoa (Spain) Abraham Fisher & Gabi Amitai Israel Institute of Biological Research (Israel) www.fondap-crcp.cl